Cell Stem Cell
Author:
Keywords:
COVID-19, Fibrosis, Humans, Kidney, Organoids, Post-Acute COVID-19 Syndrome, SARS-CoV-2, chronic kidney disease, fibrosis, human iPSC kidney organoids, kidney injury, protease blocker, Science & Technology, Life Sciences & Biomedicine, Cell & Tissue Engineering, Cell Biology, TRANSCRIPTION FACTOR, GENE-EXPRESSION, CHOROID-PLEXUS, INJURY, ORIGIN, CELLS, MYOFIBROBLASTS, RECONSTRUCTION, PROGENITORS, MECHANISMS, COVID Moonshot consortium, 06 Biological Sciences, 11 Medical and Health Sciences, Developmental Biology, 31 Biological sciences, 32 Biomedical and clinical sciences
Abstract:
Kidney failure is frequently observed during and after COVID-19, but it remains elusive whether this is a direct effect of the virus. Here, we report that SARS-CoV-2 directly infects kidney cells and is associated with increased tubule-interstitial kidney fibrosis in patient autopsy samples. To study direct effects of the virus on the kidney independent of systemic effects of COVID-19, we infected human-induced pluripotent stem-cell-derived kidney organoids with SARS-CoV-2. Single-cell RNA sequencing indicated injury and dedifferentiation of infected cells with activation of profibrotic signaling pathways. Importantly, SARS-CoV-2 infection also led to increased collagen 1 protein expression in organoids. A SARS-CoV-2 protease inhibitor was able to ameliorate the infection of kidney cells by SARS-CoV-2. Our results suggest that SARS-CoV-2 can directly infect kidney cells and induce cell injury with subsequent fibrosis. These data could explain both acute kidney injury in COVID-19 patients and the development of chronic kidney disease in long COVID.